SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001209191-12-040317
Filing Date
2012-08-03
Accepted
2012-08-03 19:29:09
Documents
1
Period of Report
2012-08-01
Filing Date Changed
2012-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3293
  Complete submission text file 0001209191-12-040317.txt   4690
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address MORRIS CORP. CENTER I; BLDG. B; 4TH FLR. 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
COLES N ANTHONY (Reporting) CIK: 0001197018 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 121008105